Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety
CADTH
Record ID 32014000221
English
Authors' recommendations:
Findings from the included meta-analysis on the comparative clinical efficacy and safety of intranasal triamcinolone and beclomethasone dipropionate in the treatment of allergic rhinitis showed that both drugs had similar efficacy in reducing nasal and ocular symptoms, but intranasal triamcinolone is safer than beclomethasone in terms of risk of epistaxis, long-term effects on growth, and systemic ocular effects.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/jan-2013/RC0423%20Triamcinolone%20vs%20Beclomethasone%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Administration, Intranasal
- Beclomethasone
- Rhinitis
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.